Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jan 26;376(4):399.
doi: 10.1056/NEJMc1615564.

Ipilimumab Adjuvant Therapy in Melanoma

Alexander M M Eggermont  1 , Stefan Suciu  2 , Alessandro Testori  3
Affiliations
Comment

Ipilimumab Adjuvant Therapy in Melanoma

Alexander M M Eggermont et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
    Eggermont AM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, Lebbé C, Ferraresi V, Smylie M, Weber JS, Maio M, Bastholt L, Mortier L, Thomas L, Tahir S, Hauschild A, Hassel JC, Hodi FS, Taitt C, de Pril V, de Schaetzen G, Suciu S, Testori A. Eggermont AM, et al. N Engl J Med. 2016 Nov 10;375(19):1845-1855. doi: 10.1056/NEJMoa1611299. Epub 2016 Oct 7. N Engl J Med. 2016. PMID: 27717298 Free PMC article. Clinical Trial.
  • Ipilimumab Adjuvant Therapy in Melanoma.
    Ianiro G, Gasbarrini A, Cammarota G. Ianiro G, et al. N Engl J Med. 2017 Jan 26;376(4):398. doi: 10.1056/NEJMc1615564. N Engl J Med. 2017. PMID: 28125193 No abstract available.
  • Ipilimumab Adjuvant Therapy in Melanoma.
    Copur MS, Ramaekers R, Crockett D. Copur MS, et al. N Engl J Med. 2017 Jan 26;376(4):398-9. doi: 10.1056/NEJMc1615564. N Engl J Med. 2017. PMID: 28125194 No abstract available.

MeSH terms

Substances

LinkOut - more resources